Tvardi Therapeutics (TVRD) Shares Issued (2013 - 2026)
Tvardi Therapeutics (TVRD) posted Shares Issued of $822040.0 for Q1 2026, down 32.19% sequentially from $1.2 million in Q4 2025, and up 624.35% YoY from $113487.0 in Q1 2025.
Tvardi Therapeutics (TVRD) Shares Issued (2013 - 2026) Analysis & Trends
Tvardi Therapeutics has reported Shares Issued for 14 years, with the latest figure at $822040.0 in Q1 2026.
- Quarterly Shares Issued rose 624.35% year-over-year to $822040.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $822040.0 (up 624.35% YoY) and the FY2025 annual result came in at $1.2 million, up 66.29% from the prior year.
- Shares Issued slipped to $822040.0 in Q1 2026 per TVRD's latest filing, from $1.2 million in the prior quarter.
- Over five years, Shares Issued peaked at $9.0 million in Q1 2023 and troughed at $113487.0 in Q1 2025.
- A 5-year average of $3.7 million and a median of $1.2 million in 2025 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2024 and 2026: Shares Issued sank 97.28% in 2024, then soared 624.35% in 2026.
- Over 5 years, Shares Issued stood at $640787.0 in 2022, then climbed by 2.71% to $658138.0 in 2023, then advanced by 10.77% to $729010.0 in 2024, then surged by 66.29% to $1.2 million in 2025, then slumped by 32.19% to $822040.0 in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $822040.0, $1.2 million, and $686194.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Tvardi Therapeutics | 17.36 Mn | 17.36 Mn | - | 1.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 822,040.00 |
| Mar 31, 2026 | 822,040.00 |
| Dec 31, 2025 | 1.21 Mn |
| Dec 31, 2025 | 1.21 Mn |
| Sep 30, 2025 | 686,194.00 |
| Sep 30, 2025 | 686,194.00 |
| Jun 30, 2025 | 1.22 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | 113,487.00 |
| Mar 31, 2025 | 113,487.00 |
| Dec 31, 2024 | 729,010.00 |
| Dec 31, 2024 | 729,010.00 |
| Sep 30, 2024 | 2.28 Mn |
| Sep 30, 2024 | 2.28 Mn |
| Jun 30, 2024 | 6.07 Mn |
| Jun 30, 2024 | 6.07 Mn |
| Mar 31, 2024 | 244,904.00 |
| Mar 31, 2024 | 244,904.00 |
| Dec 31, 2023 | 658,138.00 |
| Dec 31, 2023 | 658,138.00 |